Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 04, 2021
Results from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) study.
Journal: Expert opinion on drug delivery
Published: October 29, 2011
Showing 1-2 of 2
Last Updated: 09/26/2026